Lifecole, SL

Lifecole, SL is a Barcelona-based health technology company focused on enhancing patient engagement through a unique digital health management platform that facilitates real-time communication between patients and healthcare providers. Founded in 2020 in Barcelona, Spain, Lifecole, SL specializes in health technology solutions. The company has executed 2 deals, with its most recent fundraising round occurring on September 29, 2022. Lifecole raised EUR 750,000 in a Seed round led by Aulaplaneta, with participation from ATRESMEDIA, Bonsai Venture Capital, and Yuantai Investment Partners.

The company is led by CEO Belen Aresti, who co-founded Lifecole alongside Eric Canova and Óscar Santos. Lifecole specializes in innovative health technology solutions that focus on enhancing patient engagement and streamlining healthcare delivery. Their core product offerings include a digital health management platform designed to facilitate real-time communication between patients and healthcare providers, ultimately aiming to improve health outcomes. The platform supports various functionalities such as appointment scheduling, medication reminders, and access to personal health records, making it an essential tool for both healthcare professionals and patients.

Lifecole primarily serves hospitals, clinics, and individual healthcare practitioners in North America and Europe, addressing the need for efficient healthcare management solutions in these regions. By leveraging technology, Lifecole seeks to bridge gaps in patient care, enhance the overall healthcare experience, and empower users to take charge of their health. In 2022, Lifecole reported a revenue of EUR 22,153,477. 80.

The company utilizes a subscription-based revenue model, allowing healthcare institutions and individual practitioners to access their digital health management platform. Clients typically enter into annual contracts that provide various tiers of service, generating revenue through direct sales to healthcare providers and institutions. Following the Seed funding round in September 2022, which raised EUR 750,000, Lifecole plans to utilize the capital to support the expansion of its digital health management platform. The company is focusing on developing new features and enhancing its functionalities to better serve healthcare providers and patients.

Additionally, Lifecole aims to expand into new markets across Europe and North America by the end of 2023.